Overview

Clinical Trial to Assess the Safety and Efficacy of Investigational Product in Patients Due to Hypospadias Treatment Failure

Status:
Recruiting

Trial end date:
2023-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this trial is to assess the safety and efficacy of Holour in patients suffering from hypospadias treatment failure. Holour is intended for urethral replacement and is made from ex vivo expanded autologous oral mucosal cells including stem cells.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Holostem Terapie Avanzate s.r.l.

Collaborators:

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
University of Modena and Reggio Emilia